SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 24th, 2023 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 24th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 20, 2023, between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).